First Trust Advisors LP Amgen Inc Transaction History

First Trust Advisors LP

$95 Billion
Q2 2024

A detailed history of First Trust Advisors LP transactions in Amgen Inc stock. As of the latest transaction made, First Trust Advisors LP holds 405,473 shares of AMGN stock, worth $128 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

405,473

Previous 510,257 20.54%

Holding current value

$128 Million

Previous $145 Million 12.67%

% of portfolio

0.13%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $27.5 Million - $33.5 Million	-104,784 Reduced 20.54%	405,473 $127 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $21.9 Million - $26.5 Million	-81,554 Reduced 13.78%	510,257 $145 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $21 Million - $23.6 Million	-81,959 Reduced 12.16%	591,811 $170 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $160 Million - $198 Million	-730,045 Reduced 52.0%	673,770 $181 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $4.69 Million - $5.54 Million	21,872 Added 1.58%	1,403,815 $312 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $20 Million - $24.3 Million	88,455 Added 6.84%	1,381,943 $334 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $7.49 Million - $9.51 Million	-32,683 Reduced 2.46%	1,293,488 $340 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $884,147 - $997,157	3,939 Added 0.3%	1,326,171 $299 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $30.2 Million - $33.6 Million	-130,872 Reduced 9.01%	1,322,232 $322 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $35.2 Million - $39 Million	-160,600 Reduced 9.95%	1,453,104 $351 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $179 Million - $204 Million	898,059 Added 125.49%	1,613,704 $363 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $121 Million - $141 Million	-568,039 Reduced 44.25%	715,645 $152 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $24.9 Million - $27.6 Million	106,480 Added 9.05%	1,283,684 $313 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $9.74 Million - $11.3 Million	-43,877 Reduced 3.59%	1,177,204 $293 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $34.6 Million - $41.2 Million	160,041 Added 15.08%	1,221,081 $281 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $10.7 Million - $12 Million	45,797 Added 4.51%	1,061,040 $270 Million
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $6.11 Million - $7.49 Million	-30,868 Reduced 2.95%	1,015,243 $239 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $35,354 - $46,889	194 Added 0.02%	1,046,111 $212 Million
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $3.12 Million - $4.01 Million	-16,474 Reduced 1.55%	1,045,917 $252 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $23.4 Million - $28 Million	-134,317 Reduced 11.22%	1,062,391 $206 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $54.2 Million - $63.6 Million	325,404 Added 37.35%	1,196,708 $221 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $35.1 Million - $39.5 Million	193,914 Added 28.63%	871,304 $166 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $2.49 Million - $2.91 Million	-13,954 Reduced 2.02%	677,390 $132 Million
Q3 2018 Oct 25, 2018	BUY	$185.29 - $208.89 $41.7 Million - $47 Million	224,916 Added 48.22%	691,344 $143 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $23.8 Million - $26.7 Million	-143,183 Reduced 23.49%	466,428 $86.1 Million
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $3.49 Million - $4.07 Million	-20,572 Reduced 3.26%	609,611 $104 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $12.7 Million - $14.2 Million	75,135 Added 13.54%	630,183 $110 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $92.9 Million - $106 Million	555,048	555,048 $103 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Amgen Inc Transaction History